The Ocular Surface Insight (OSI) Dry Eye Masterclass & Symposium took place on the 27th and 28th of March 2025 at the Copthorne Tara Hotel in London, with the attendance of 186 delegates, bringing together experts, researchers, and clinicians from around the world to share insights into dry eye disease (DED) management.
As a foundation doctor, this event was an excellent opportunity to expand my knowledge of evidence-based treatments and emerging innovations for this increasingly prevalent condition. The two-day symposium featured 26 lectures and 10 workshops, covering exciting topics such as immunology, corneal biology, and novel therapies like intense pulsed light (IPL) and lowlevel light therapy. Discussions on dendritic cells, T cells, and immunomodulators in DED provided valuable insights into its inflammatory mechanisms. Sessions also explored corneal scarring, nerve tracking, and biological cleansing for ocular health, broadening our understanding of these complex conditions.
A highlight of the event was the debate sessions, where optometrists and ophthalmologists tackled controversial topics in eyecare. These discussions engaged the audience and encouraged critical thinking. Additionally, holistic approaches to DED management were explored, including talks on nutrition, menopause, and hormone replacement therapy, reinforcing the need for a multifaceted, patient-focused approach to treatment. A particularly inspiring moment was the keynote lecture by Professor Ken Nischal on paediatric ocular surface disease, dedicated to the late Professor Michael O’Keeffe, who was a pioneering paediatric eye surgeon.
The hands-on workshops provided practical experience with advanced diagnostic tools and treatment technologies, guided by industry experts. Sessions covered refractive surgery outcomes, alternative therapies, and new treatment options beyond traditional eye drops. These workshops were particularly beneficial, allowing attendees to apply theoretical knowledge in a clinical setting.
The symposium also served as a platform for junior doctors and trainees to present their research. I was among nine junior doctors showcasing posters on ocular surface disease, presenting mine on artificial intelligence in DED and its potential impact on diagnostics and treatment.
Beyond the academic sessions, the event provided a fantastic networking opportunity. Meeting ophthalmologists, optometrists and industry professionals gave me deeper insights into career pathways, research opportunities, and advancements in eyecare. These connections reinforced my passion for ophthalmology and helped me consider my next steps in the preparation for the speciality training application.
Overall, the OSI Dry Eye Masterclass & Symposium 2025 was an exceptional event that combined scientific education, practical training, and networking in a meaningful way. With DED becoming more prevalent, staying informed about innovative, evidencebased treatments is crucial. The next OSI event will take place on the 23rd and 24th of April 2026, promising another opportunity for professionals to engage with the latest advancements in ocular surface disease.
